Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: Natalia Vapniarsky x
  • Refine by Access: All Content x
Clear All Modify Search

The concept of a one-health approach in regenerative medicine has gained tremendous momentum in the scientific and public communities in recent years. Knowledge derived from this approach informs innovative biomedical research, clinical trials, and practice. The ultimate goal is to translate regenerative strategies for curing diseases and improving the quality of life in animals and people. Building and fostering strong and enthusiastic interdisciplinary and transdisciplinary collaboration between teams with a wide range of expertise and backgrounds is the cornerstone to the success of the one-health approach and translational sciences. The veterinarian’s role in conducting clinical trials in client-owned animals with naturally occurring diseases is critical and unique as it may potentially inform human clinical trials. The veterinary regenerative medicine and surgery field is on a steep trajectory of discoveries and innovations. This manuscript focuses on oromaxillofacial-region regeneration to exemplify how the concept of interdisciplinary and transdisciplinary collaboration and the one-health approach influenced the authors’ work experience at the University of California-Davis.

Open access
in American Journal of Veterinary Research
History and Physical Examination Findings

A 7-year-old 8.6-kg (18.9-lb) castrated male Pug was evaluated because of chronic nasal discharge. Respiratory signs, which started 3 weeks following ingestion of coffee beans, had been noticed for the past 2.5 years and had developed into respiratory distress. Six months after the onset of clinical signs, the patient developed a mucoid discharge from the left nostril. Rhinoscopy revealed hyperemia and mucus in the left nasal cavity. The mucoid discharge resolved temporarily with the use of amoxicillin–clavulanic acid (14.5 mg/kg [6.59 mg/lb], PO, q 12 h), but occasional treatment with neomycin–polymyxin B–dexamethasone ophthalmic drops (in

Restricted access
in Journal of the American Veterinary Medical Association